N/A
Completed N=63
A Study to Evaluate the Product Performance of the PureVision®2 High Definition (HD) Contact Lens
Source: ClinicalTrials.gov NCT01416142 ↗Enrolled (actual)
63
Serious AEs
0.0%
Results posted
Dec 2013
Primary outcomePrimary: Visual Acuity — -0.029; -0.043 logMAR
Summary
The objective of this study is to evaluate the product performance of PureVision2 HD contact lenses.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Visual Acuity |
-0.029; -0.043 | — |
| SECONDARY Preference for Test Lens |
46; 9; 0; 24; 20; 12 | — |
Eligibility Criteria
Inclusion Criteria
- Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings
- Subjects must be myopic or hyperopic and require lens correction in each eye
- Subjects must own a pair of spectacles and the spectacle prescription must have been updated or confirmed as correct within the last 2 years.
Exclusion Criteria
- Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
- Any systemic disease affecting ocular health.
- Using any systemic or topical medications that will affect ocular physiology or lens performance.
- Allergic to any component in the Biotrue multi-purpose solution
Data sourced from ClinicalTrials.gov (NCT01416142). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.